Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 31, 2012. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Fourth Quarter 2011 Performance Report, to be issued that morning.

To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com and click on the “Pfizer Quarterly Corporate Performance – Fourth Quarter 2011” link in the Investor Presentations section located on the lower right-hand corner of that page. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today. Participants are advised to pre-register in advance of the conference call.

You can also listen to the conference call by dialing either (866) 246-2545 in the United States and Canada or (706) 634-2365 outside of the United States and Canada. The password is “Fourth Quarter Earnings”.

Visitors to www.pfizer.com will be able to view and listen to an archived copy of the webcast of the conference call.



CONTACT:

Pfizer Inc.
Media Relations
Joan Campion, 212-733-2798
or
Investor Relations
Suzanne Harnett, 212-733-8009

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Mental Health  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Zantac and some OTC antacids.

Roche is steamrolling with Ocrevus, and to maintain that lead, its touting long-term data that show the earlier it’s given, the better patients do.

New data shows a significant reduction in relapse rates in patients taking Novartis' repurposed cancer drug ofatumumab.